A novel approach to support implementation of biosimilars within a UK tertiary hospital

Aims To assess the transfer of patients treated with originator biological therapies to biosimilar products in a large UK tertiary referral hospital reflecting practice within the National Health Service (NHS) using prospectively collected data by a hospital‐based registry administered by the Biologics Steering Group (BSG). Methods We analysed data collected prospectively in a hospital‐based registry in a large NHS tertiary referral hospital in...